Screening for Chlamydia in Low-Risk Pregnant Patients
Author Information
Author(s): Robert K. Gribble, Jean M. Ricci-Goodman, Richard L. Berg
Primary Institution: Marshfield Clinic
Hypothesis
Is universal prenatal screening for Chlamydia trachomatis appropriate for low-risk obstetric patients?
Conclusion
Routine prenatal screening for Chlamydia trachomatis is not appropriate for low-risk patients.
Supporting Evidence
- The overall prevalence of Chlamydia trachomatis was found to be 2.0%.
- Only 0.5% of low-risk patients tested positive for Chlamydia.
- 5.7% of high-risk patients tested positive for Chlamydia.
- The difference in prevalence between low-risk and high-risk groups was statistically significant.
Takeaway
The study found that most low-risk pregnant women do not have Chlamydia, so testing everyone isn't necessary.
Methodology
Patients were screened for Chlamydia trachomatis using an antigen test at their first prenatal visit, and classified as high or low risk based on specific criteria.
Potential Biases
Potential bias in risk factor assessment due to reliance on patient self-reporting.
Limitations
The study was conducted in a specific rural population, which may not represent other demographics.
Participant Demographics
The study involved a rural, central Wisconsin population, predominantly Caucasian, with a majority having private health insurance and at least a high school education.
Statistical Information
P-Value
<0.001
Confidence Interval
95% CI 0.2-1.2 for low-risk; 95% CI 3.7-8.2 for high-risk
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website